GBM combination therapy using nanocarriers from different sources loaded with epigenetic drugs. (IMAGE)

Tsinghua University Press

GBM combination therapy using nanocarriers from different sources loaded with epigenetic drugs.

Caption

Schematic illustration of GBM combination therapy using nanocarriers from different sources loaded with epigenetic drugs. Vorinostat and Panobinostat are HDACis, Azacitidine and Decitabine are DNMTis, and Tazemetostat is the HMTi.

Credit

Nano Research, Tsinghua University Press

Usage Restrictions

News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.